BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15583604)

  • 1. Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity?
    Cozzio A; Hafner J; Kempf W; Häffner A; Palmedo G; Michaelis S; Gilliet M; Zimmermann D; Burg G
    J Am Acad Dermatol; 2004 Dec; 51(6):1014-7. PubMed ID: 15583604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature.
    Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D
    Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas.
    Yang CC; Lee JY; Chen W
    Eur J Dermatol; 2003; 13(5):493-6. PubMed ID: 14693498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica.
    Shieh S; Mikkola DL; Wood GS
    Arch Dermatol; 2001 Mar; 137(3):305-8. PubMed ID: 11255329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile ulceronecrotic Mucha-Habermann disease in a 34-month-old boy: a case report and review of the literature.
    Perrin BS; Yan AC; Treat JR
    Pediatr Dermatol; 2012; 29(1):53-8. PubMed ID: 21906156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.
    Tsianakas A; Hoeger PH
    Br J Dermatol; 2005 Apr; 152(4):794-9. PubMed ID: 15840118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile ulceronecrotic Mucha-Habermann disease associated with herpes simplex virus type 2.
    Smith JJ; Oliver GF
    J Am Acad Dermatol; 2009 Jan; 60(1):149-52. PubMed ID: 19103367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Febrile ulceronecrotic Mucha-Habermann disease].
    Arellano Lorca J; Yáñez Silva I; Soto Vilches F; Luna Heine A; Corredoira Salum Y
    Rev Med Chil; 2016 Sep; 144(9):1214-1217. PubMed ID: 28060985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature.
    Aytekin S; Balci G; Duzgun OY
    Dermatol Online J; 2005 Dec; 11(3):31. PubMed ID: 16409927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature.
    Miyamoto T; Takayama N; Kitada S; Hagari Y; Mihara M
    J Clin Pathol; 2003 Oct; 56(10):795-7. PubMed ID: 14514790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) associated with parvovirus infection.
    Nanda A; Alshalfan F; Al-Otaibi M; Al-Sabah H; Rajy JM
    Am J Dermatopathol; 2013 Jun; 35(4):503-6. PubMed ID: 23612031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile ulceronecrotic Mucha-Habermann disease: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Assaf M; Alakad R; Amer H; Nofal E; Yosef A
    Int J Dermatol; 2016 Jul; 55(7):729-38. PubMed ID: 26695875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis lichenoides: pathophysiology, classification, and treatment.
    Khachemoune A; Blyumin ML
    Am J Clin Dermatol; 2007; 8(1):29-36. PubMed ID: 17298104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis lichenoides and its subtypes.
    Bowers S; Warshaw EM
    J Am Acad Dermatol; 2006 Oct; 55(4):557-72; quiz 573-6. PubMed ID: 17010734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease.
    Marenco F; Fava P; Fierro MT; Quaglino P; Bernengo MG
    Dermatol Ther; 2010; 23(4):419-22. PubMed ID: 20666830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucha-Habermann disease and its febrile ulceronecrotic variant.
    Tsuji T; Kasamatsu M; Yokota M; Morita A; Schwartz RA
    Cutis; 1996 Aug; 58(2):123-31. PubMed ID: 8864599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate.
    Alratrout J; Alshammasi F; Ansari N
    Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Febrile ulceronecrotic Mucha-Habermann disease in adult patient successfully treated with systemic corticosteroid.
    Nassif PW; Godoy DA; Nakandakari S; Alves CJ; Soares CT
    An Bras Dermatol; 2010; 85(6):891-4. PubMed ID: 21308316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of febrile ulceronecrotic Mucha-Habermann disease responsive to systemic corticosteroids.
    Rai E; Kamzan A; Boozalis E; Hogeling M; Fong K
    Pediatr Dermatol; 2023; 40(3):573-575. PubMed ID: 36573550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.